10 Apr MOEHS worldwide
Today, business internationalization has become one of the key aspects of MOEHS when it comes to seeking the growth of the organization and opening new markets throughout the world. Going...
News
19 Mar The Moehs group will be at CPHI North America 2019, one of the largest pharmaceutical meetings in the world.
CPhi North America will be held from April 30 to May 2 at McCormick Place, Chicago, Illinois. The Moehs group will participate as an exhibitor and will also be represented by...
14 Mar Moehs group will be represented at CPHI Japan, which will be held from 18 to 20 March in Tokyo.
CPhI Japan will take place at the Big Sight Exhibition Center in Tokyo (Japan) between March 18 and 20. The CPhI Japan is, together with the CPhI China, the most important...
11 Mar Moehs group will be represented at CPHI South East Asia, which will be held from 12 to 14 March in Bangkok (Thailand)
In 2019, CPhI South East Asia will be held at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand (12-14 March). Moehs group, in its international presence, will be represented...
04 Feb Moehs Group receives the “Best Supplier” award from Sinopharm China.
Sinopharm, our client in China, has awarded us a prize for the best supplier, in recognition of the good work performed during the past year. The annual supplier trophy of our...
01 Feb Update of MOEHS GMP certificates
Compliance with the GMP (Good Manufacturing Practice) standards for manufacturers of Active Pharmaceutical Ingredients is one of the priorities of our Quality department at MOEHS. The regulation applies to manufacturing operations...
29 Jan Moehs group will attend at DCAT Week, the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries
It will be held from March 18 to 21, 2019 in New York City (USA) and is organized by the Drug, Chemical & Associated Technologies Association (DCAT). Moehs Group will attend...
23 Jan Moehs Group obtains the Certificate of suitability of Monographs of the European Pharmacopoeia (CEP), granted by the European Directorate for the Quality of Medicines (EDQM), as a manufacturer of DULOXETINA HCL.
Moehs, as a manufacturer of active ingredients, believes that quality is of paramount importance. Our goal is the manufacture of products that fully satisfy the needs of our customers, respecting...
21 Jan New trials of MOEHS samples begin with two reference laboratories of the University of Cantabria.
Two new reference laboratories have been approved by the U.S. Food and Drug Administration (FDA) for the testing of samples supplied by MOEHS Cantabria. The collaboration has great value, given...
10 Jan Start a new promotion of the Master of fine chemistry and polymers of the UAB with which Moehs collaborates.
After the success of the initial promotion of the Autonomous University of Barcelona, in January 2019 a new stage begins for students who join the internship, which will last a...